Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Keratosis, Actinic 12Melanoma 2Keratosis 2Carcinoma, Basal Cell 2Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Hepatoblastoma 1Eyelid Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Bowen's Disease 1Adenocarcinoma, Sebaceous 1

Interventions

Cyclophosphamide 3liposomal amphotericin B 2fludarabine 2Voriconazole 2Radiotherapy 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Mesna 2Itraconazole 2Ifosfamide 2Flow Cytometry 2Filgrastim 2Etoposide 2Carboplatin 2Amplified Fragment Length Polymorphism Analysis 2tipifarnib 1sargramostim 1pembrolizumab 1fludarabine phosphate 1entinostat 1aldesleukin 1X-Rays 1Valacyclovir 1Thrombopoietin 1Therapeutics 1Stem Cell Transplantation 1Specimen Handling 1Sirolimus 1Ritonavir 1Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × Cryotherapy × Dermatologic × Clear all
NCT05302921 2025-01-01

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Children's National Research Institute

Phase 2 Completed
5 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Melanoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡